Ascendis Pharma A/SNASDAQ:ASND
No Matches were found for
- LAST PRICE107.6900
- TODAY'S CHANGE (%)-1.1100 (-1.0202%)
- Bid / Lots101.7100/ 1
- Ask / Lots110.0000/ 1
- Open / Previous Close107.6700 / 108.8000
- Day Range
- 52 Week Range
- Volume1,471,632
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASND |
|---|---|---|
| 09:32 ET | 4062 | 108.38 |
| 09:33 ET | 2073 | 107.48 |
| 09:35 ET | 1500 | 108.52 |
| 09:37 ET | 2416 | 109.12 |
| 09:39 ET | 1755 | 108.91 |
| 09:42 ET | 800 | 108.58 |
| 09:44 ET | 1481 | 108.95 |
| 09:46 ET | 1500 | 109.57 |
| 09:48 ET | 1500 | 109.585 |
| 09:50 ET | 1300 | 109.86 |
| 09:51 ET | 4126 | 110.25 |
| 09:53 ET | 7048 | 109.64 |
| 09:55 ET | 200 | 109.43 |
| 09:57 ET | 3000 | 109.35 |
| 10:00 ET | 510 | 109.06 |
| 10:02 ET | 3032 | 109.735 |
| 10:04 ET | 800 | 110.12 |
| 10:06 ET | 2688 | 110.8 |
| 10:08 ET | 3256 | 110.8 |
| 10:09 ET | 1700 | 110.94 |
| 10:11 ET | 8771 | 110.53 |
| 10:13 ET | 1000 | 110.58 |
| 10:15 ET | 3310 | 110.45 |
| 10:18 ET | 8212 | 110.98 |
| 10:20 ET | 2400 | 110.825 |
| 10:22 ET | 3600 | 111.08 |
| 10:24 ET | 3600 | 111.06 |
| 10:26 ET | 2174 | 111.24 |
| 10:27 ET | 7915 | 110.815 |
| 10:29 ET | 1200 | 110.325 |
| 10:31 ET | 17475 | 110.39 |
| 10:33 ET | 14815 | 109.98 |
| 10:36 ET | 9492 | 110.37 |
| 10:38 ET | 1400 | 109.77 |
| 10:40 ET | 2016 | 110.14 |
| 10:42 ET | 2919 | 109.97 |
| 10:44 ET | 5800 | 110.175 |
| 10:45 ET | 2203 | 110.055 |
| 10:47 ET | 2331 | 110.22 |
| 10:49 ET | 1600 | 110.02 |
| 10:51 ET | 550 | 109.91 |
| 10:54 ET | 3390 | 109.99 |
| 10:56 ET | 2559 | 109.725 |
| 10:58 ET | 400 | 109.78 |
| 11:00 ET | 2310 | 109.51 |
| 11:02 ET | 4502 | 109.635 |
| 11:03 ET | 1334 | 109.55 |
| 11:05 ET | 11605 | 110.04 |
| 11:07 ET | 2683 | 109.705 |
| 11:09 ET | 1100 | 109.695 |
| 11:12 ET | 5335 | 109.45 |
| 11:14 ET | 1307 | 109.48 |
| 11:18 ET | 2031 | 109.5 |
| 11:20 ET | 2835 | 108.79 |
| 11:21 ET | 1200 | 109.07 |
| 11:23 ET | 100 | 109.045 |
| 11:25 ET | 700 | 109.03 |
| 11:27 ET | 2859 | 109.195 |
| 11:30 ET | 500 | 109.185 |
| 11:32 ET | 1561 | 109.51 |
| 11:34 ET | 800 | 109.53 |
| 11:36 ET | 2145 | 109.2 |
| 11:38 ET | 900 | 108.85 |
| 11:39 ET | 1000 | 108.265 |
| 11:41 ET | 1107 | 108.19 |
| 11:43 ET | 600 | 107.99 |
| 11:45 ET | 200 | 107.84 |
| 11:48 ET | 1700 | 107.84 |
| 11:50 ET | 2023 | 108.265 |
| 11:52 ET | 1400 | 108.18 |
| 11:54 ET | 700 | 107.925 |
| 11:56 ET | 401 | 107.875 |
| 11:57 ET | 1400 | 107.965 |
| 11:59 ET | 3402 | 108.135 |
| 12:01 ET | 2889 | 107.9 |
| 12:03 ET | 2035 | 108.17 |
| 12:06 ET | 1100 | 108.045 |
| 12:08 ET | 300 | 108.02 |
| 12:10 ET | 1503 | 108.09 |
| 12:12 ET | 600 | 108.115 |
| 12:14 ET | 1910 | 107.99 |
| 12:15 ET | 700 | 107.98 |
| 12:17 ET | 300 | 107.975 |
| 12:19 ET | 4621 | 107.99 |
| 12:21 ET | 1300 | 108.02 |
| 12:24 ET | 1972 | 107.63 |
| 12:26 ET | 1300 | 107.8 |
| 12:28 ET | 2500 | 107.915 |
| 12:30 ET | 100 | 108.065 |
| 12:32 ET | 200 | 107.765 |
| 12:33 ET | 500 | 107.8 |
| 12:35 ET | 2374 | 107.82 |
| 12:37 ET | 1300 | 107.865 |
| 12:39 ET | 3970 | 108.08 |
| 12:42 ET | 1000 | 107.95 |
| 12:44 ET | 500 | 108.145 |
| 12:46 ET | 1154 | 108.04 |
| 12:48 ET | 1969 | 108.075 |
| 12:50 ET | 4700 | 108.14 |
| 12:51 ET | 200 | 108.25 |
| 12:53 ET | 600 | 108.46 |
| 12:55 ET | 2400 | 108.615 |
| 12:57 ET | 170 | 108.2101 |
| 01:00 ET | 100 | 108.4 |
| 01:02 ET | 2012 | 109.115 |
| 01:04 ET | 600 | 109.25 |
| 01:08 ET | 4299 | 109.535 |
| 01:09 ET | 10112 | 109.125 |
| 01:11 ET | 43400 | 109.05 |
| 01:13 ET | 3000 | 109.21 |
| 01:15 ET | 1100 | 109.05 |
| 01:18 ET | 2140 | 108.8 |
| 01:20 ET | 1253 | 108.865 |
| 01:22 ET | 1700 | 108.89 |
| 01:24 ET | 3362 | 109.3 |
| 01:26 ET | 600 | 109.3 |
| 01:27 ET | 1200 | 109.6 |
| 01:29 ET | 2302 | 109.63 |
| 01:31 ET | 3300 | 109.295 |
| 01:33 ET | 40007 | 108.975 |
| 01:36 ET | 3256 | 109.06 |
| 01:40 ET | 431 | 109.02 |
| 01:42 ET | 3178 | 108.73 |
| 01:44 ET | 2399 | 108.77 |
| 01:45 ET | 3991 | 108.72 |
| 01:47 ET | 6180 | 108.7 |
| 01:49 ET | 6553 | 109.025 |
| 01:51 ET | 400 | 108.97 |
| 01:56 ET | 2540 | 108.86 |
| 01:58 ET | 3316 | 108.89 |
| 02:00 ET | 4500 | 108.83 |
| 02:02 ET | 6664 | 108.6262 |
| 02:03 ET | 1831 | 108.52 |
| 02:05 ET | 1000 | 108.54 |
| 02:07 ET | 5163 | 108.74 |
| 02:09 ET | 2400 | 108.69 |
| 02:12 ET | 1700 | 108.68 |
| 02:14 ET | 3822 | 108.775 |
| 02:16 ET | 6115 | 108.94 |
| 02:18 ET | 1200 | 108.945 |
| 02:20 ET | 2500 | 108.925 |
| 02:21 ET | 800 | 108.835 |
| 02:23 ET | 700 | 108.62 |
| 02:25 ET | 1445 | 108.535 |
| 02:27 ET | 6112 | 108.665 |
| 02:30 ET | 600 | 108.695 |
| 02:32 ET | 10037 | 108.36 |
| 02:34 ET | 1400 | 108.41 |
| 02:36 ET | 1700 | 108.355 |
| 02:38 ET | 2600 | 108.595 |
| 02:39 ET | 2600 | 108.255 |
| 02:41 ET | 2600 | 108.24 |
| 02:43 ET | 3217 | 108.22 |
| 02:45 ET | 7185 | 108.16 |
| 02:48 ET | 3400 | 108.09 |
| 02:50 ET | 1600 | 107.93 |
| 02:52 ET | 3399 | 107.77 |
| 02:54 ET | 2700 | 107.79 |
| 02:56 ET | 3148 | 107.76 |
| 02:57 ET | 6911 | 107.93 |
| 02:59 ET | 3400 | 107.895 |
| 03:01 ET | 3800 | 107.785 |
| 03:03 ET | 7464 | 107.87 |
| 03:06 ET | 7903 | 107.87 |
| 03:08 ET | 2525 | 107.915 |
| 03:10 ET | 7873 | 108.04 |
| 03:12 ET | 3800 | 107.985 |
| 03:14 ET | 2800 | 107.935 |
| 03:15 ET | 6867 | 108.21 |
| 03:17 ET | 3830 | 108.165 |
| 03:19 ET | 9468 | 108.095 |
| 03:21 ET | 5887 | 107.85 |
| 03:24 ET | 9470 | 107.89 |
| 03:26 ET | 4686 | 107.975 |
| 03:28 ET | 4700 | 107.73 |
| 03:30 ET | 7604 | 107.85 |
| 03:32 ET | 3100 | 107.78 |
| 03:33 ET | 11830 | 107.895 |
| 03:35 ET | 7449 | 107.83 |
| 03:37 ET | 3100 | 107.775 |
| 03:39 ET | 9641 | 107.855 |
| 03:42 ET | 5700 | 107.685 |
| 03:44 ET | 4900 | 107.66 |
| 03:46 ET | 16294 | 107.75 |
| 03:48 ET | 8109 | 107.775 |
| 03:50 ET | 18432 | 108.475 |
| 03:51 ET | 13244 | 108.67 |
| 03:53 ET | 24142 | 108.395 |
| 03:55 ET | 20526 | 108.095 |
| 03:57 ET | 18354 | 108.085 |
| 04:00 ET | 22209 | 107.69 |
Nov 29, 2023
Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan, from 4:30AM ET on Wednesday Nov 29, 2023 by Dow Jones
4:30AM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 20, 2023
Nov 16, 2023
DJ Positive Outcome Seen on Ascendis TransCon Refile -- Market Talk, from 1:03PM ET on Thursday Nov 16, 2023 by Dow Jones
1:03PM ET on Thursday Nov 16, 2023 by Dow Jones
Nov 15, 2023
Ascendis Pharma Resubmits NDA for TransCon(TM) PTH to the U.S. FDA, from 8:00AM ET on Wednesday Nov 15, 2023 by Dow Jones
8:00AM ET on Wednesday Nov 15, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ascendis Pharma A/S | 6.2B | -9.3x | --- |
Apellis Pharmaceuticals Inc | 7.4B | -11.9x | --- |
Cerevel Therapeutics Holdings Inc | 7.4B | -16.5x | --- |
BridgeBio Pharma Inc | 5.7B | -8.3x | --- |
Karuna Therapeutics Inc | 7.8B | -18.8x | --- |
ImmunoGen Inc | 7.8B | -97.5x | --- |
Company Information
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Contact Information
- Headquarters
- Tuborg Boulevard 12HELLERUP, Denmark 2900
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Albert Cha
- President, Chief Executive Officer, Executive Director, Member of the Executive Board
- Jan Moller Mikkelsen
- Chief Financial Officer, Executive Vice President, Member of the Executive Board
- Scott Smith
- Executive Vice President, Chief Administrative Officer
- Lotte Soenderbjerg
- Executive Vice President - Nonclinical Development and Bioanalysis
- Vibeke Breinholt
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.2B |
|---|---|
Revenue (TTM) | $163.5M |
Shares Outstanding | 57.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-11.54 |
Book Value | $4.96 |
P/E Ratio | -9.3x |
Price/Sales (TTM) | 38.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -372.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
